AFP and hepatocellular carcinoma: 100% of the control samples were classified as negative by AFP and 61% of HCC were classified properly (63% Stage A, 59% Stage B, 58% Stage C, 68% Stage D) (Fig. 8A prediction, Fig. 8D ROC).